Red Cell Distribution Width,,NT-proBNP and cTnT in Acute Myocardial Infraction Patient
Detrmination of the Relationship Between Red Cell Distribution Width ,NT-proBNP and cTnT in Acute Myocardial Infraction Patients
1 other identifier
observational
30
1 country
1
Brief Summary
the study is to investigate the relationship of several parameters of complete blood count (CBC) including RDW with N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponin T (cTnT) in a cohort of acute myocardial infarction (AMI) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2022
CompletedFirst Posted
Study publicly available on registry
October 26, 2022
CompletedStudy Start
First participant enrolled
November 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 13, 2023
CompletedNovember 15, 2022
November 1, 2022
7 months
October 23, 2022
November 10, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
(CBC)
measurement of CBC will be performed at the time of admission and by the time of discharge.
6 months
(NT-proBNP
measurement of serum NT-proBNP levels will be performed at the time of admission and by the time of discharge.
6 months
(cTnT)
measurement of cTnT levels will be performed at the time of admission and by the time of discharge
6 months
Interventions
complete blood count (CBC) including RDW with N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponin T (cTnT) in a cohort of acute myocardial infarction (AMI) patients.
Eligibility Criteria
• All patients included in the study will be subjected to: 1. Full history: 1. Personal history: e.g. age, sex and smoking. 2. Family history of cardiac diseases 3. Medical history of: Hypertension, Ischemic heart disease, prior coronary artery bypass grafting, Prior Percutaneous coronary intervention, Prior Stroke, Prior Atrial fibrillation, therapeutic history 2. Detailed clinical examination 3. Electrocardiogram 4. Laboratory investigation: 1. Routine investigation in the form of CBC including RDW 2. Specific investigation which include NT-proBNP and cTnT
You may not qualify if:
- Patient with:
- Decompensated heart failure
- Pulmonary hypertention
- Acute pulmonary embolism
- Septic shock
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University Hospital
Sohag, Egypt
Related Publications (3)
Nascimento BR, Brant LCC, Marino BCA, Passaglia LG, Ribeiro ALP. Implementing myocardial infarction systems of care in low/middle-income countries. Heart. 2019 Jan;105(1):20-26. doi: 10.1136/heartjnl-2018-313398. Epub 2018 Sep 29.
PMID: 30269080BACKGROUNDBarberi C, van den Hondel KE. The use of cardiac troponin T (cTnT) in the postmortem diagnosis of acute myocardial infarction and sudden cardiac death: A systematic review. Forensic Sci Int. 2018 Nov;292:27-38. doi: 10.1016/j.forsciint.2018.09.002. Epub 2018 Sep 17.
PMID: 30269044BACKGROUNDAlaour B, Liew F, Kaier TE. Cardiac Troponin - diagnostic problems and impact on cardiovascular disease. Ann Med. 2018 Dec;50(8):655-665. doi: 10.1080/07853890.2018.1530450. Epub 2018 Nov 21.
PMID: 30265127BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Abdelhady R Abdel-Gawad, assistant professor
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor at clinical and chemical pathology department
Study Record Dates
First Submitted
October 23, 2022
First Posted
October 26, 2022
Study Start
November 13, 2022
Primary Completion
June 13, 2023
Study Completion
July 13, 2023
Last Updated
November 15, 2022
Record last verified: 2022-11